HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D.
Papatheodoridi M, Sevastianos V, Zachou K, Christodoulou D, Koskinas J, Deutsch M, Alexopoulou A, Elefsiniotis I, Triantos C, Gigi E, Androutsakos T, Karagiannakis D, Mani I, Dimitroulopoulos D, Mela M, Sinakos E, Michopoulos S, Mimidis K, Papadopoulos N, Kontos A, Veretanos C, Lymperopoulos D, Giannoulis G, Papadimitropoulos V, Avramopoulou E, Papatheodoridi A, Pantzios S, Vasilieva L, Kranidioti H, Koullias E, Psychos N, Fytili P, Vlachogiannakos J, Cholongitas E, Manolakopoulos S, Goulis I, Dalekos G, Papatheodoridis G.
Papatheodoridi M, et al. Among authors: dimitroulopoulos d.
Liver Int. 2025 Jul;45(7):e70151. doi: 10.1111/liv.70151.
Liver Int. 2025.
PMID: 40522200
Free PMC article.